| Product NDC: | 16729-035 |
| Proprietary Name: | Anastrozole |
| Non Proprietary Name: | Anastrozole |
| Active Ingredient(s): | 1 mg/1 & nbsp; Anastrozole |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 16729-035 |
| Labeler Name: | Accord Healthcare Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA090568 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20100628 |
| Package NDC: | 16729-035-10 |
| Package Description: | 30 TABLET in 1 BOTTLE, PLASTIC (16729-035-10) |
| NDC Code | 16729-035-10 |
| Proprietary Name | Anastrozole |
| Package Description | 30 TABLET in 1 BOTTLE, PLASTIC (16729-035-10) |
| Product NDC | 16729-035 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Anastrozole |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20100628 |
| Marketing Category Name | ANDA |
| Labeler Name | Accord Healthcare Inc |
| Substance Name | ANASTROZOLE |
| Strength Number | 1 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Aromatase Inhibitor [EPC],Aromatase Inhibitors [MoA] |